Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medradiopreparat, officially known as the Federal Center for Design and Development of Radiopharmaceutical Preparations (FCDDRP), is a leading Russian state-owned enterprise specializing in the production of radiopharmaceuticals. Established in 1967 and operating under the Federal Medical-Biological Agency (FMBA), the facility is a critical supplier of isotopes for diagnostic and therapeutic nuclear medicine. Its extensive product portfolio includes iodine-131 for thyroid conditions, technetium-99m generators, and a variety of organ-specific imaging kits. Beyond manufacturing, the center provides specialized engineering and design services for nuclear medicine infrastructure across the Russian Federation. The plant maintains GMP-compliant production lines to support oncology, cardiology, and endocrinology departments nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medradiopreparat Plant.